International Journal of Molecular Sciences, Volume 25, Issue 9
2024 May-1 - 478 articles
Cover Story: Janus kinase inhibitors (JAKis) are small molecules that have shown great promise in the treatment of psoriasis and psoriatic arthritis. JAKis seem to be as efficient as other well-established treatments for these highly-prevalent inflammatory conditions and have led to the improvement of cutaneous and articular manifestations, systemic inflammation and quality of life, while maintaining an acceptable safety profile. JAKis act by blocking the evolutionarily conserved Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway involved in downstream signaling for cytokines using type I or II receptors. This scoping review aims to provide an integrated understanding of the range of effects that JAKis have on the whole spectrum of psoriasis manifestations. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.